AlterH.J.. Chronic consequences of non-A, non-B hepatitis. In: SeeffL.B., LewisJ.H., eds. Current perspectives in hepatology.New York: Plenum Medical Books, 1989; 83–97.
2.
BruixJ., BarreraJ.M., CalvetX.Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.Lancet1989; 2: 1004–6.
3.
PolS., RomeoR., ZinsB.Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications.Kidney Int1993; 44: 1097–100.
4.
RosellóL., FernándezE., López TalaveraJ.C., BrugueraM., MontoliuJ.. Hepatitis C in hemodialysis patients: prognosis and diagnostic value of transjugular liver biopsy. In: EliahouH.E., lainaA., Bar-KhayimY., eds. XII International Congress of Nephrology. Abstracts. Jerusalem, Israel, June 13-15 1993; 394.
5.
NietoJ., FerrerasI., MoraF.Hepatitis C virus (HCV) in hemodialysis (HD) patients: correlation between clinical, biochemical and histological findings (Abstract).Kidney Int1993; 44: 1485.
6.
CarameloC., OrtizA., AguileraB.Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus.Am J Kidney Dis1993; 22: 822–8.
7.
PonzE., CampistolJ.M., BrugueraM.. Hepatitis C virus infection among kidney transplant recipients.Kidney Int1991; 40: 748–51.
8.
MoralesJ.M., CampoC., CastellanosG.The impact of hepatitis C after renal transplantation: a clinicopathological study (Abstract). 5th Congress of the European Society of Organ Transplantation, 1991; 105.
9.
RothD., FernandezJ.A., BurkeG.W., EsquenaziV., MillerJ.. Detection of antibody to hepatitis C virus in renal transplant recipients.Transplantation1991; 51: 396–400.
10.
Di BisceglieA., HoofnagleJ.H.. Therapy of chronic hepatitis C with alpha interferon.The answer? or more questions? Hepatology1991; 13: 601–3.
11.
HoofnagleJ.H., MullenK.D., JonesD.B.Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon.N Engl J Med1986; 315: 1575–8.
12.
EspinosaM., GonzálesR., MataM.Treatment of chronic hepatitis C in haemodialysis patients with interferon (Abstract).Nephrol Dial Transplant1993; 8: 967.
13.
BarrilG., TraverJ.A.for the Spanish HCV Multicentric Study Group. Epidemiological study of anti-hepatitis C virus (HCV) prevalence in 83 dialysis units in Spain (Abstract).Nephrol Dial Transplant1993; 8: 966.
14.
LinD-Y, LinH-H, HuangC-C, LiawY-F. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan.Am J Kidney Dis1993; 21: 288–91.
15.
NiuM.T., AlterM.J., KristensenC., MargolisH.S.. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus.Am J Kidney Dis1992; 19: 345–52.
16.
BeccariM., SorgatoG., RizzoloL., VeneroniG.. Anti-HCV reactivity in dialysis patients: discrepancies between first and second generation tests.Nephron1993; 63: 238.
17.
WelchH.G., MeehanK.R., GoodnoughL.T.. Prudent strategies for elective red blood cell transfusion.Ann Intern Med1992; 116: 393–402.
18.
KorbetS.M.. Comparison of haemodialysis and peritoneal dialysis in the management of anaemia retated to chronic renal disease.Semin Nephrol1989; 9(Suppl 1): 9–15.
19.
JadoulM., CornuC., van Ypersele de StrihouC.and the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study.Kidney Int1993; 44: 1322–6.
20.
PetrosilloN., ScacciaF., PuroV., IppolitoG.. Hepatitis C transmission in dialysis.Nephron1993; 63: 115.
21.
PascualJ., TeruelJ.L., LiañoF., OrtuñoJ.. Home hemodialysis protects against hepatitis C virus transmission.Nephron1993; 64: 314.
22.
MullerG.Y., ZabaletaM.E., ArminioA.Risk factors for dialysis-associated hepatitis C in Venezuela.Kidney Int1992; 41: 1055–8.
23.
OguchiH., MiyasakaM., TokunagaS.Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units.Clin Nephrol1992; 38: 36–43.
24.
NiuM.T., ColemanP.J., AlterM.J.. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members.Am J Kidney Dis1993; 22: 568–73.
25.
RoblesN.R., Gomez AinsuaC., CruzA.. Lack of transmission of hepatitis C virus in a haemodialysis unit.Nephrol Dial Tranplant1992; 7: 981–2.
26.
Centers for Disease Control: what control measures should be taken when hemodialysis patients are suspected of having non-A, non-B hepatitis? Atlanta, GA, CDC, Hepatitis Surveillance Report, No. 49, 1985; 3–4.
27.
MMWR Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health-care settings.JAMA1988; 260: 462–5.
28.
FaveroM.S.. Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis.Infect Control1985; 6: 301–5.
29.
ChanS-W, SimmondsP., McOmishF.Serological responses to infection with three different types of hepatitis C virus.Lancet1991; 338: 1391.
30.
FarciP., AlterH.J., GovindarajanS.Lack of protective immunity against reinfection with hepatitis C virus.Science1992; 256: 135–40.
31.
PicciottoA., VaragonaG., GurreriG.Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.Nephrol Dial Transplant1993; 8: 1115–7.
32.
DussolB., ChicheporticheC., CantaloubeJ-FDetection of hepatitis C infection or polymerase chain reaction among hemodialysis patients.Am J Kidney Dis1993; 22: 574–80.
33.
ChanT.M., LokA.S.F., ChengI.K.P., ChanR.T.. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.Hepatology1993; 17: 5–8.
34.
NordenfeltE., LofgrenB., WidellA.Hepatitis C virus infection in hemodialysis patients in Southern Sweden: epidemiological, clinical, and diagnostic aspects.J Med Virol1993; 40: 266–70.
35.
SheuJ-C, LeeS-H, WangJ-T, ShihL-N, WangT-H, ChenD-S. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan.J Med Virol1992; 37: 108–112.